SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-21-000003
Filing Date
2021-01-07
Accepted
2021-01-07 07:33:41
Documents
16
Period of Report
2021-01-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20210107.htm   iXBRL 8-K 33548
2 EX-99.1 pcrx-december2020revenuepr.htm EX-99.1 23196
8 PACIRA BIOSCIENCES LOGO pacirabiosciencesa011a.jpg GRAPHIC 27796
  Complete submission text file 0001396814-21-000003.txt   244331

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20210107.xsd EX-101.SCH 2430
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20210107_cal.xml EX-101.CAL 718
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20210107_def.xml EX-101.DEF 1655
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20210107_lab.xml EX-101.LAB 24270
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20210107_pre.xml EX-101.PRE 12654
9 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20210107_htm.xml XML 11027
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 21512998
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences